SNDX - Syndax Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SNDX is currently covered by 11 analysts with an average price target of $30.16. This is a potential upside of $14.33 (90.52%) from yesterday's end of day stock price of $15.83.

Syndax Pharmaceuticals's activity chart (see below) currently has 70 price targets and 93 ratings on display. The stock rating distribution of SNDX is 97.96% BUY and 2.04% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.13% with an average time for these price targets to be met of 228.53 days.

Highest price target for SNDX is $49, Lowest price target is $23, average price target is $30.16.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 12-Nov-2024. First documented stock forecast 31-Mar-2016.

Currently out of the existing stock ratings of SNDX, 48 are a BUY (97.96%), 1 are a HOLD (2.04%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$49

$33.17 (209.54%)

$47

5 days ago
(12-Nov-2024)

6/26 (23.08%)

$31.83 (185.38%)

606

Buy

$33

$17.17 (108.46%)

$30

10 days ago
(07-Nov-2024)

0/2 (0%)

$11.54 (53.77%)

Buy

$41

$25.17 (159.00%)

$42

1 months 3 days ago
(14-Oct-2024)

0/5 (0%)

$21.18 (106.86%)

Buy

$34

$18.17 (114.78%)

$30

3 months 1 days ago
(16-Aug-2024)

3/8 (37.5%)

$14.07 (70.60%)

355

Buy

$33

$17.17 (108.46%)

$34

3 months 2 days ago
(15-Aug-2024)

2/6 (33.33%)

$13.04 (65.33%)

119

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SNDX (Syndax Pharmaceuticals) average time for price targets to be met?

On average it took 228.53 days on average for the stock forecasts to be realized with a an average price target met ratio 27.13

Which analyst has the current highest performing score on SNDX (Syndax Pharmaceuticals) with a proven track record?

MADHU KUMAR

Which analyst has the most public recommendations on SNDX (Syndax Pharmaceuticals)?

Madhu Kumar works at GOLDMAN SACHS and has 8 price targets and 5 ratings on SNDX

Which analyst is the currently most bullish on SNDX (Syndax Pharmaceuticals)?

Edward White with highest potential upside - $33.17

Which analyst is the currently most reserved on SNDX (Syndax Pharmaceuticals)?

David Lebowitz with lowest potential downside - $5.17

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?